Public Health Webinar Series on Blood Disorders
CDC’s Division of Blood Disorders (DBD) is proud to offer its Public Health Webinar Series on Blood Disorders. The purpose of this series is to provide evidence-based information on new research, interventions, emerging issues of interest in blood disorders, as well as innovative approaches in collaborations and partnerships. We invite you to join us in this series.
Archives for 2018
March 15, 2018
Michael Cassidy, MD
Assistant Professor of Surgery
Boston University School of Medicine
Section of Surgical Oncology
Boston Medical Center
Perioperative Venous Thromboembolism: Risk Assessment and Risk-Stratified Prophylaxis for Surgical Patients
In this webinar, Michael Cassidy, MD, discusses what is known about risk factors, risk assessment, and perioperative VTE prophylaxis, including extended postoperative prophylaxis. He also shares the outcomes of a standardized program of risk stratification and risk-based VTE prophylaxis regimens.
February 22, 2018
Barbara A. Konkle, MD
Associate Chief Scientific Officer
Director, Hemostasis, Platelet Immunology and Genomics Laboratory
Associate Director, Washington Center for Bleeding Disorders
Professor of Medicine, University of Washington
In this webinar, Dr. Konkle describes the hemophilia genomics project called My Life, Our Future (MLOF). She shares results of genetic analyses of participant samples and discusses potential research advances through the MLOF Research Repository.
Archives for 2017
November 9, 2017
Jeffrey A. Kline, MD
Professor and Vice Chair of Research
Department of Emergency Medicine, Indiana University School of Medicine
In this webinar, Dr. Kline describes the public health burden of pulmonary embolism (PE) in the emergency department and what can be done to ensure an early diagnosis. He discusses rapid and safe methods to exclude PE, risk stratification for patients who have PE, and the essential elements of home treatment protocol for low risk PE.
October 12, 2017
C. Michael Gibson, MD
Professor of Medicine, Harvard Medical School
Founder and Editor-in-Chief of WikiDoc
In this webinar, Dr. Gibson describes the public health burden of thrombosis, an often preventable underlying pathology of heart attack, thromboembolic stroke, and venous thromboembolism, the top three cardiovascular killers. He shares the latest information on key advances in preventing thrombosis.
September 21, 2017
Wendy Owens, MA
Director of Research
Hemophilia Federation of America
It’s All About CHOICE: Findings from a Survey for People Seeking Care Outside of Hemophilia Treatment Centers
In this webinar, Ms. Owens presents an overview of the CHOICE Project (Community Having Opportunity to Influence Care Equity). CHOICE is a project in partnership between the Hemophilia Federation of America and the Centers for Disease Control & Prevention. She discusses the strategies used to integrate the bleeding disorders patient perspective into the development of the CHOICE survey. She also describes survey methods and preliminary data describing the characteristics of survey respondents.
May 18, 2017
Robert Sidonio, Jr., MD, MSc
Associate Director of Hemostasis and Thrombosis, Children’s Healthcare of Atlanta
Assistant Professor of Pediatrics, Emory University Hospital
In this webinar, Dr. Sidonio discusses the prevalence of bleeding disorders in women and girls and reviews patient and provider awareness of bleeding disorders. He also provides an overview to management approaches for these conditions and describes the array of assessment tools currently available to healthcare providers.
March 16, 2017
Michael B. Streiff, MD, FACP
Associate Professor of Medicine and Pathology
Associate Faculty, Armstrong Institute for Patient Safety and Quality
Medical Director, Johns Hopkins Anticoagulation Management Service and Outpatient Clinics
Medical Director, Special Coagulation Laboratory
Senior Consultant, Johns Hopkins Comprehensive Hemophilia Treatment Center
Johns Hopkins Medical Institutions, Baltimore, Maryland
In this webinar, Dr. Streiff describes strategies that the Johns Hopkins Venous Thromboembolism (VTE) Collaborative undertook to reduce the occurrence of VTE in healthcare settings. He discusses the role of evidence-based clinical decision support order sets in improving VTE prevention performance.
February 16, 2017
Mark Skinner, JD
National Hemophilia Foundation
President & CEO, Institute for Policy Advancement Ltd.
Menaka Pai, BSc, MSc, MD, FRCPC
Assistant Professor, Department of Medicine
Associate Member, Department of Pathology and Molecular Medicine
Consultant Laboratory Hematologist, Hamilton Regional Laboratory Medicine Program, McMaster University
Steven Pipe, MD
Chair, Medical and Scientific Advisory Council,
National Hemophilia Foundation
Director, Division of Pediatric Hematology and Oncology
Pediatric Medical Director, Hemophilia and Coagulation Disorders Program
Director, Special Coagulation Laboratory, University of Michigan
The National Hemophilia Foundation (NHF) initiated the development of an evidence-based clinical practice guideline to identify best practices in delivery of care for people with hemophilia in order to improve patient outcomes.
In this webinar, presenters describe the research that formed the basis for the guideline and discuss how the guideline will be put into action.
For more information on the webinar series, please contact Cindy Sayers at firstname.lastname@example.org.
- Page last reviewed: February 16, 2018
- Page last updated: March 16, 2018
- Content source: